Nephrology Publications

2017

  1. Catalytic iron in acute myocardial infarction complicated by cardiogenic shock – A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G, Traeder F, Lele SS, Rajapurkar MM, Mukhopadhyay B, de Waha S, Desch S, Eitel I, Schuler G, Adams V, Thiele H.
    Int J Cardiol. 2017 Jan 15;227:83-88. doi: 10.1016/j.ijcard.2016.11.072. Epub 2016 Nov 9.
  2. Indian chronic kidney disease study: Design and methods.
    Kumar V, Yadav AK, Gang S, John O, Modi GK, Ojha JP, Pandey R, Parameswaran S, Prasad N, Sahay M, Varughese S, Baid-Agarwal S, Jha V.
    Nephrology (Carlton). 2017 Apr;22(4):273-278.
  3. Characterization of NPHS2 gene polymorphisms associated to steroid resistance nephrotic syndrome in Indian children
    Joshi BB, Mistry KN, Gang S, Koringa PG, Joshi CG.
    Gene. 2017 Sep 10;628:134-140

2016

  1. Lack of electron microscopy hinders correct renal biopsy diagnosis: A study from India.
    Kurien AA, Larsen C, Rajapurkar M, Bonsib SM, Walker P.
    Ultrastruct Pathol. 2016;40(1):14-7. doi: 10.3109/01913123.2015.1120837.

2015

  1. Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery.
    Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Rawn JD, Frendl G, Waikar SS.
    Kidney Int. 2015 May;87(5):1046-54. doi: 10.1038/ki.2014.374. Epub 2015 Jan 7.
  2. Recent advances in understanding the pathogenesis of atherosclerosis in CKD patients.
    Shah SV, Shukla AM, Bose C, Basnakian AG, Rajapurkar M.
    J Ren Nutr. 2015 Mar;25(2):205-8. doi: 10.1053/j.jrn.2014.10.024. Epub 2015 Jan 1. Review.
  3. Comparative effects of sirolimus-eluting versus bare metal stents on neointimal hyperplasia in balloon –injured external iliac artery of rabbits.
    Atul Patel, Pinesh Parikh, Deepak Patil, Anila Mathew, Suhas Lele,Mohan Rajapurkar, Pradip Patil, Akhilesh Kumar, Priti Vani.
    Turkish Journal of Veterinary and Animal Sciences 2015 39:369-375
  4. In silico analysis of functional nsSNPs in human TRPC6 gene associated with steroid resistant nephrotic syndrome
    Joshi BB, Koringa PG, Mistry KN, Patel AK, Gang S, Joshi CG. Gene.
    Gene. 2015 Nov 1;572(1):8-16. doi: 10.1016/j.gene.2015.06.069. Epub 2015 Jun 27.

2014

  1. Plasma catalytic iron, AKI, and death among critically ill patients.
    Leaf DE, Rajapurkar M, Lele SS, Mukhopadhyay B, Waikar SS.
    Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1849-56. doi: 10.2215/CJN.02840314. Epub 2014 Sep 4.
  2. Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study.
    Farag YM, Mittal BV, Keithi-Reddy SR, Acharya VN, Almeida AF, C A, Ballal HS, Gaccione P, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rajapurkar MM, Rana DS, Sreedhara R, Sinha DK, Shah BV, Sunder S, Sharma RK, Seetharam S, Raju TR, Singh AK.
    BMC Nephrol. 2014 Mar 6;15:42. doi: 10.1186/1471-2369-15-42.
  3. A Single Arm, Prospective, Open Label, Multicentre Study for Evaluation of Efficacy and Safety of IV CERA for Treatment of Chronic Renal Anaemia in Dialysis Patients not Currently Treated with ESA.
    Georgy K Nainan, Vivek R Pathak, Sonal S Dalal, Sanjiv Saxena, Dinesh Mittal , T Ravi Raju, Gokulnath, Rajan Isaac, MM Rajapurkar, DS Rana, Bharat V Shah, Deepak S Ray, CM Thiagarajan, Ratan M Jha, Anil A Kukreja, Rupesh R Pophale.
    JAPI 2014; 62 (3):232-236.
  4. Bacteriological profile and drug resistance patterns of blood culture isolates in a tertiary care nephrourology teaching institute
    Kalpesh Gohel,* Amit Jojera, Shailesh Soni, Sishir Gang, Ravindra Sabnis, and Mahesh Desai
    Biomed Res Int. 2014; 2014: 153747.

2013

  1. Role of multi-detector computed tomography (MDCT) in management of post percutaneous nephrolithotomy (PCNL) bleeding.
    Ganpule AP, Shah DH, Ganpule SA, Sabnis RB, Rajapurkar MM, Desai MR.
    F1000Res. 2013 Nov 22;2:253. doi: 10.12688/f1000research.2-253.v1. eCollection 2013.
  2. Epidemiology and risk factors of chronic kidney disease in India – results from the SEEK (Screening and Early Evaluation of Kidney Disease) study.
    Singh AK, Farag YM, Mittal BV, Subramanian KK, Reddy SR, Acharya VN, Almeida AF, Channakeshavamurthy A, Ballal HS, P G, Issacs R, Jasuja S, Kirpalani AL, Kher V, Modi GK, Nainan G, Prakash J, Rana DS, Sreedhara R, Sinha DK, V SB, Sunder S, Sharma RK, Seetharam S, Raju TR, Rajapurkar MM.
    BMC Nephrol. 2013 May 28;14:114. doi: 10.1186/1471-2369-14-114.
  3. Impact of catalytic iron on mortality in patients with acute coronary syndrome exposed to iodinated radiocontrast-The Iscom Study.
    Lele SS, Mukhopadhyay BN, Mardikar MM, Patel TA, Vasavada AK, Banker DN, Kapasi KD, Chauhan VC, Chawla KC, Raju SR, Hiremath SS, Chinchole SS, Rajapurkar MM.
    Am Heart J. 2013 May;165(5):744-51. doi: 10.1016/j.ahj.2013.02.016. Epub 2013 Mar 26.
  4. Human leukocyte antigen alleles, genotypes and haplotypes frequencies in renal transplant donors and recipients from West Central India.
    Patel JS, Patel MM, Koringa PG, Shah TM, Patel AK, Tripathi AK, Mathew A, Rajapurkar MM, Joshi CG.
    Indian J Hum Genet. 2013 Apr;19(2):219-32. doi: 10.4103/0971-6866.116122.
  5. Prognostic evaluation of catalytic iron in patients with acute coronary syndromes.
    Steen DL, Cannon CP, Lele SS, Rajapurkar MM, Mukhopadhyay B, Scirica BM, Murphy SA, Morrow DA.
    Clin Cardiol. 2013 Mar;36(3):139-45. doi: 10.1002/clc.22089.
  6. Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease.
    Rajapurkar MM, Hegde U, Bhattacharya A, Alam MG, Shah SV.
    Toxicol Mech Methods. 2013 Jan;23(1):5-10. doi: 10.3109/15376516.2012.730558.
  7. Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis.
    Rajapurkar MM1, Lele SS, Malavade TS, Kansara MR, Hegde UN, Gohel KD, Gang SD, Shah SV, Mukhopadhyay BN.
    Indian J Nephrol. 2013 Sep;23(5):332-7. doi: 10.4103/0971-4065.116293.
  8. Long term belatacept exposure maintains efficacy and safety at 5 years; results from the long term extension of the BENEFIT study.
    Rostaing L, Vincenti F, Grinyo J, Rice KM, Bresnahan B, Steinberg S, Gang S, Gaite LE, Moal MC, Mondragon – Ramirez GA, Kothari J, Pupim L, Larsen CP
    American Journal of Transplantation 2013; 13: 2875–2883

2012

  1. What do we know about chronic kidney disease in India: first report of the Indian CKD registry.
    Rajapurkar MM, John GT, Kirpalani AL, Abraham G, Agarwal SK, Almeida AF, Gang S, Gupta A, Modi G, Pahari D, Pisharody R, Prakash J, Raman A, Rana DS, Sharma RK, Sahoo RN, Sakhuja V, Tatapudi RR, Jha V.
    BMC Nephrol. 2012 Mar 6;13:10. doi: 10.1186/1471-2369-13-10.
  2. Association of catalytic iron with cardiovascular disease.
    Rajapurkar MM, Shah SV, Lele SS, Hegde UN, Lensing SY, Gohel K, Mukhopadhyay B, Gang S, Eigenbrodt ML.
    Am J Cardiol. 2012 Feb 1;109(3):438-42. doi: 10.1016/j.amjcard.2011.09.032. Epub 2011 Nov 8.
  3. Fifteen years’ experience of treating atherosclerotic renal artery stenosis by interventional nephrologists in India.
    Hegde U, Rajapurkar M, Gang S, Khanapet M, Durugkar S, Gohel K, Aghor N, Ganju A, Dabhi M.
    Semin Dial. 2012 Jan-Feb;25(1):97-104. doi: 10.1111/j.1525-139X.2011.00962.x. Epub 2011 Oct 13.
  4. Experiences regarding intervention in renal transplantations by nephrologists.
    Kalpesh Gohel, Mohan Rajapurkar
    Indian Journal of Transplantation 2012, Vol. 6, No.3; 83-87

2011

  1. The role of catalytic iron in acute kidney injury.
    Shah SV, Rajapurkar MM, Baliga R.
    Clin J Am Soc Nephrol. 2011 Oct;6(10):2329-31. doi: 10.2215/CJN.08340811. No abstract available.
  2. Urinary catalytic iron in obesity.
    Thethi TK, Parsha K, Rajapurkar M, Mukhopadhyay B, Shah S, Yau CL, Japa S, Fonseca V.
    Clin Chem. 2011 Feb;57(2):272-8. doi: 10.1373/clinchem.2010.154757. Epub 2010 Dec 28.
  3. Urinary catalytic iron in patients with type 2 diabetes without microalbuminuria-a substudy of the ACCORD Trial.
    Thethi T, Rajapurkar M, Walker P, McDuffie R, Goff DC Jr, Probstfield J, Yau CL, Shah S, Christians U, Buse J, Fonseca V.
    Clin Chem. 2011 Feb;57(2):341-4. doi: 10.1373/clinchem.2010.155887.

2010

  1. Deceased-donor renal transplantation program in India.
    Abraham G, Shroff S, Nayak KS, Matcha J, Rajapurkar M, Reddy YN, Sundaram V, Reddy YN.
    Kidney Int. 2010 Mar;77(5):378-80. doi: 10.1038/ki.2009.494.
  2. Burden of disease – prevalence and incidence of renal disease in India.
    Rajapurkar M, Dabhi M
    Clinical Nephrology 2010 ;74(1):S9-12

2009

  1. Management of non-neoplastic renal hemorrhage by transarterial embolization.
    Jain V, Ganpule A, Vyas J, Muthu V, Sabnis RB, Rajapurkar MM, Desai MR.
    Urology. 2009 Sep;74(3):522-6. doi: 10.1016/j.urology.2008.11.062. Epub 2009 Jul 9.
  2. Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes.
    Lele S, Shah S, McCullough PA, Rajapurkar M.
    EuroIntervention. 2009 Aug;5(3):336-42.
  3. Radiation nephropathy is not mitigated by antagonists of oxidative stress.
    Cohen EP, Fish BL, Irving AA, Rajapurkar MM, Shah SV, Moulder JE.
    Radiat Res. 2009 Aug;172(2):260-4. doi: 10.1667/RR1739.
  4. The role of labile iron in kidney disease and treatment with chelation.
    Shah SV, Rajapurkar MM.
    Hemoglobin. 2009;33(5):378-85. doi: 10.3109/03630260903212233.
  5. Vascular complications following renal Transplantation.
    Sishir Gang,Rajapurkar MM,
    Journal of Nephrology and Renal Transplantation 2009; 2(1); 122-132.
  6. Is carbon dioxide a safe and good alternative for diatrizoate meglumine as a contrast in digital subtraction angiography?
    Hegde U, Rajapurkar MM,
    Indian Journal of Nephrology 2009;19(1):15-19

2008

  1. Percutaneous endovascular management of recurrent aneurysm of transplant renal artery anastomosed to internal iliac artery.
    Hegde UN, Rajapurkar MM, Gang SD, Lele SS.
    Indian J Urol. 2008 Jul;24(3):411-3. doi: 10.4103/0970-1591.42629.

2007

  1. Comparative evaluation of ultrasound guided renal biopsy using 14 and 16 gauge tru-cut biopsy needles in adult dogs
    Patel, PV Parikh,DB Patil, NH Kelawala, Rajapurkar MM, PH Tank,PB Patil
    Indian Journal of Veterinary Surgery 2007; 28(2):133-134.
  2. Catheterization of carotid artery for iliac stenting in rabbits.
    PB Patil,DB Patil, PV Parikh,NH Kelawala,Mayuri Rajapurkar, S.Lele, Rajapurkar MM.
    Indian Journal of Veterinary Surgery 2007;28(2):133-134.
  3. Subtle dysfunction after Radiocontrast administration in prospective renal donors : Does N-acetylcysteine have a role in its prevention
    K.Gohel,M.Khanpet,B.Mukhopadhyaya,U.Hegde,S.Gang, Rajapurkar MM.
    Indian Journal of Nephrology 2007;17(4): 160-164.
  4. Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure.
    Rajapurkar M, Hegde U, Rokhade M, Gang S, Gohel K.
    Nat Clin Pract Nephrol. 2007 Oct;3(10):573-7.
  5. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (Gene Vac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM, Gang S, Dabhi M, Kulkarni PS.
    J Nephrol. 2007 Sep-Oct;20(5):596-601.
  6. Ischaemia imaging in type 2 diabetic kidney transplant candidates-is coronary angiography essential?
    Gang S, Dabhi M, Rajapurkar MM.
    Nephrol Dial Transplant. 2007 Aug;22(8):2334-8. Epub 2007 Jun 5.
  7. Kidney transplantation in abnormal bladder.
    Mishra SK, Muthu V, Rajapurkar MM, Desai MR.
    Indian J Urol. 2007 Jul;23(3):299-304. doi: 10.4103/0970-1591.33728.
  8. Oxidants in chronic kidney disease.
    Shah SV, Baliga R, Rajapurkar M, Fonseca VA.
    J Am Soc Nephrol. 2007 Jan;18(1):16-28.

2006

  1. Overcoming the Hurdle of Post transplant Infection.
    Rajapurkar MM, Gohel K.
    The Journal of General Medicine 2006;18(2):35-45.

2005

  1. CoAuthor: Best clinical Practice Guidelines For Chronic Kidney Disease in India.
    Indian Journal of Nephrology Supplement 2005; 15(3).

2004

  1. Enzymuria pattern in early post renal transplant period: Diagnostic usefulness in graft dysfunction.
    Mukhopadhyay B, Chinchole S, Lobo V, Gang S, Rajapurkar M.
    Indian J Clin Biochem. 2004 Jul;19(2):14-9. doi: 10.1007/BF02894251.
  2. Interventional Radiology in Renal Disorders.
    Rajapurkar MM.
    The Journal of General Medicine 2004;16(3):56-62.

2003

  1. ARF in obstetric patients.
    Valentine Lobo, Sishir Gang,Anil Ganju, Lalit Shah, Rajapurkar MM, VN Acharya.
    The Journal of Renal Sciences 2003;6(2):6-11.

2002

  1. Successful local thrombolytic treatment of inferior vena caval and left renal thrombus in a nephrotic patient.
    Valentine Lobo, Sishir Gang, Rajapurkar MM, VN Acharya.
    The Journal of Renal Sciences 2002; 5(4):20-22.
  2. Effect of reuse of hollow fiber dialyzers upon Kt/V[urea]:a prospective study,
    V.Lobo,S.Gang, Rajapurkar MM.
    Indian Journal of Nephrology 2002;12:40-46.
  3. Metabolic acidosis following hemodialysis
    V.Lobo,S.Gang,LJ Shah,A.Ganju, PK Pandya, Rajapurkar MM, VN Acharya:
    Indian Journal of Nephrology 2002;12:52-55.

2001

  1. Clinical Forum renal involvement in bacterial Endocarditis.
    V Lobo,S.Gang,S Kale,N Kulkarni, LJ Shah, Rajapurkar MM, VN Acharya
    The Journal of Renal Sciences 2001;4(2):33-37.
  2. Left ventricular disorders in patients of end stage renal disease entering hemodialysis programme
    SA Kale, NS Kulkarni, S Gang, A Ganju, L Shah, MM Rajapurkar
    Indian J Nephrol 2001;11:12-16
  3. Renal Sciences – Clinical Forum Renal Involvement in Bacterial Endocarditis
    V Lobo, S Gang, S Kale, N Kulkarni, L Shah, MM Rajapurkar & VN Acharya
    The Journal of Renal Sciences, Vol.4,No.2,July-September 2001

2000

  1. Outcome of renal transplantation in patients with calculus renal disease.
    S.Gang,RB Sabnis, S Kale,N Kulkarni, SH Patel, MR Desai, Rajapurkar MM.
    Transplantation Proceedings 2000;32:1855-56.
  2. Atherosclerotic Renal Artery Stenosis [ARAS] Manifestations & Management
    Rajapurkar MM.
    Journal of Renal Sciences 2000;3(1): 9-14.

1999

  1. Ischaemic Nephropathy in Proceeding International CME in Nephrology” Organized by Department of Nephrology, Institute of Medical Sciences, Banaras Hindu University, Varanasi (India) Ed. R.G. Singh & Jai Prakash PP 6-9. Dr MM Rajaurkar 1999
  2. Level of urinary excretion of enzymes GAMMA glutamyl Transferase [GGT], Alanine Aminopeptidate [AAP] & N-Acetyl-D-Glucosamine [NAG] in healthy adults.
    Banibrata Mukhopadhyay, Tarkesh Mehta, Rajapurkar MM.
    Journal of Renal Sciences 1999;2(3):16-17,30.
  3. Lupus nephritis presenting as idiopathic thrombocytopenic purpura [ITP].
    Akila Vohra, Sishir Gang, Rajapurkar MM, LJ Shah, VN Acharya.
    Journal of Renal Sciences Oct-Dec 1999,Vo.2, No.3:18-21.

1998

  1. Effect of Malaria in Renal Transplant Recipient.
    Rajapurkar MM.
    Journal of Renal Sciences. 1998;1[3]: 36-39.
  2. Multiple myeloma masquarding falciparum malaria – presenting as acute renal failure.
    NK Hase, Murli Krishnan, Sishir Gang, Sanjeev Kale, Rajapurkar MM, VN Acharya.
    Journal of Renal Sciences 1998; 1(2):65-66.
  3. Renal Biopsy:Diagnostic Efficacy & Safety.
    Rajapurkar MM.
    Journal of Renal Sciences 1998;1(1):51-54.
  4. Step-wise Approach to acid-base evaluation.
    NK Hase, Rajapurkar MM.
    Journal of Renal Sciences 1998;1(2):57-62.
  5. Renin angiotensin system in health and disease.
    NK Hase, Rajapurkar MM.
    Journal of Renal Sciences 1998; 1 (1):38-43, 69-70.

1994

  1. Renal involvement in Malaria.
    Rajapurkar MM.
    Journal of Postgraduate Medicine 1994;40(3):132-134.
  2. Water treatment for Hemodialysis.
    Rajapurkar MM.
    Journal of Postgraduate Medicine 1994; 40(3):140-143.

1989

  1. Acute Renal Failure.
    Rajapurkar MM.
    Indian Perspective Glimpses of Medicine 1989, Vol.II

1983

  1. Renal complication of Diabetes Mellitus. Special issue on Diabetes Mellitus invitation article.
    Rajapurkar MM.
    Gujarat Medical Journal 1983.

1981

  1. Advances in Glomerulonephritis.
    Rajapurkar MM.
    Gujarat Medical Journal 1981.